These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24760692)

  • 21. [Efficacy of pantoprazole in the therapy of esophageal reflux disease].
    Lazebnik LB; Vasil'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):102-4. PubMed ID: 19145874
    [No Abstract]   [Full Text] [Related]  

  • 22. [Using ursodez in the treatment of refractory form of gastroesophageal reflux disease].
    Osadchuk AM; Davydkin IL
    Eksp Klin Gastroenterol; 2012; (4):74-5. PubMed ID: 23402158
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical presentations of gastroesophageal reflux disease.
    Heidelbaugh JJ; Gill AS; Van Harrison R; Nostrant TT
    Am Fam Physician; 2008 Aug; 78(4):483-8. PubMed ID: 18756656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.
    Frazzoni M; Conigliaro R; Melotti G
    Aliment Pharmacol Ther; 2011 Mar; 33(5):601-6. PubMed ID: 21198705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease.
    Dellon ES; Shaheen NJ
    Gastroenterology; 2010 Jul; 139(1):7-13.e3. PubMed ID: 20493864
    [No Abstract]   [Full Text] [Related]  

  • 26. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
    J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-reflux surgery in patients with adequate response to proton pump inhibitors - is there an indication?].
    Horstmann R; Gregor N; Classen C; Röttgermann S; Palmes D
    Z Gastroenterol; 2006 Dec; 44(12):1217-22. PubMed ID: 17163371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of symptomatic reflux episodes on Acid suppressive therapy.
    Tutuian R; Vela MF; Hill EG; Mainie I; Agrawal A; Castell DO
    Am J Gastroenterol; 2008 May; 103(5):1090-6. PubMed ID: 18445095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy-resistant gastro-oesophageal reflux disease: endoluminal treatment not yet sufficiently compared with the gold standard, the laparoscopic Nissen fundoplication].
    Draaisma WA; Fegrachi S; Simmermacher RK; Broeders IA; Smout AJ; Gooszen HG
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2553-8. PubMed ID: 19174936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic Nissen-Rossetti fundoplication is a safe and effective treatment for both Acid and bile gastroesophageal reflux in patients poorly responsive to proton pump inhibitor.
    Brillantino A; Schettino M; Torelli F; Marano L; Porfidia R; Reda G; Grassia M; Braccio B; Di Martino N
    Surg Innov; 2011 Dec; 18(4):387-93. PubMed ID: 21742660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reflux disease. How to manage when proton pump inhibitors fail?].
    Stiefelhagen P
    MMW Fortschr Med; 2014 Aug; 156(14):30. PubMed ID: 25195395
    [No Abstract]   [Full Text] [Related]  

  • 33. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
    Bajbouj M; Becker V; Phillip V; Wilhelm D; Schmid RM; Meining A
    Digestion; 2009; 80(2):112-8. PubMed ID: 19641320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients].
    Lundell L
    Lakartidningen; 2009 Feb 18-24; 106(8):502-5. PubMed ID: 19350782
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors.
    Woodland P; Sifrim D
    Curr Opin Gastroenterol; 2013 Jul; 29(4):431-6. PubMed ID: 23549342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
    Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
    J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis.
    Illueca M; Wernersson B; Henderson C; Lundborg P
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):733-40. PubMed ID: 20808247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commentary: Randomised trials of surgical and non-surgical treatment: a role model for the future.
    Blazeby JM; Barham CP; Donovan JL
    BMJ; 2008 Dec; 337():a2747. PubMed ID: 19074947
    [No Abstract]   [Full Text] [Related]  

  • 40. Proton pump inhibitor failure--what are the therapeutic options?
    Fass R
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.